Outcome measures in psoriatic arthritis clinical trials.

Soumya M. Reddy, Clifton O. Bingham

Research output: Contribution to journalReview articlepeer-review

Abstract

Outcome measures in psoriatic arthritis (PsA) have been primarily borrowed from the assessment of rheumatoid arthritis and ankylosing spondylitis, although several specific measures for PsA have been established. The advent of new therapeutic agents for the treatment of PsA has made the need for specific outcome measures for PsA more critical to evaluate the heterogeneous manifestations of this disease and features that are unique to its assessment. Several outcome measures have been validated for use in PsA clinical trials while others are being evaluated by groups such as The Group for Assessment of Psoriasis and Psoriatic Arthritis for future use in clinical trials.

Original languageEnglish (US)
Pages (from-to)299-305
Number of pages7
JournalCurrent rheumatology reports
Volume7
Issue number4
DOIs
StatePublished - Aug 2005
Externally publishedYes

ASJC Scopus subject areas

  • Rheumatology

Fingerprint Dive into the research topics of 'Outcome measures in psoriatic arthritis clinical trials.'. Together they form a unique fingerprint.

Cite this